The novel combination of CD3+/CD4+ cells with myosteatosis emerged as a highly effective indicator, offering heightened predictive efficacy for identifying recurrence and metastasis in post‐surgery gastric cancer patients. The gene discussed is CD4; the disease is gastric cancer.